London, United Kingdom, January 25, 2018 --(PR.com
)-- Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn, Kensington Forum, London, on the 16th – 17th May 2018.
Their global panel of speakers will strengthen your knowledge in key topics such as delivery technology, fill and finish process, the use of nanosystems in peptide delivery, drug solubility, weight-based dosing limits, evolving areas including polymer technologies and tackling high-volume and highly viscous drug formulations.
With most diabetes medications taking injectable form, drug makers are increasingly exploring the use of prefillable self-injection systems for their administration. Self-injection systems can give patients freedom to self-manage their disease outside of the doctor’s office. However, with this approach comes new considerations around risk mitigation.
Regulatory bodies around the world are asking drug and packaging manufacturers to ensure consistent quality throughout a drug product’s lifecycle in order to minimize risks to the patient and the drug. In this new era of treatment, the adoption of Quality by Design (QbD) principles in drug development and manufacturing is a way to put patients first. QbD delivers an improved, data-driven output, providing manufacturers with superior product and process understanding that minimizes risk, emphasizes patient-critical quality requirements and enhances drug effectiveness.
Building quality into the development and manufacturing process from the start helps ensure that high quality standards are met through commercialization and allows the industry to reach its ultimate goal: delivering safe, effective medications to patients. *http://bit.ly/2mPqJSd
Hear more about the emerging technologies within the design, packaging and manufacturing of pre-filled self-injections from Roche, as they present "Vial Based Novel Delivery Technology" when SMi welcome the expertise of Maxime Gaillot, Senior Device Engineer this May.
Below is an overview of his presentation:
Presented on Day 1 @09.50 Vial Based Novel Delivery Technology
- Weight-based dosing limits the primary packaging selection and impacts the number of potential different product presentations
- Discover how vial-based presentation can provide a solution to these complex dosing regimens
- Understand the background of vial-based presentation
- Learn the specifics of this novel delivery technology
For those looking to attend there is currently a £400 early-bird saving, ending January 31st.
Further information is available at: www.injectable-drug-delivery.com/prc
SMi presents the Launch of:
Injectable Drug Delivery
Date: 16th – 17th May 2018
Workshops: 15th May 21018
Location: Holiday Inn Kensington Forum, London UK
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: firstname.lastname@example.org
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk